Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · IEX Real-Time Price · USD
2.400
-0.210 (-8.05%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $13.25 million as of July 2, 2024. Its market cap has increased by 55.93% in one year.
Market Cap
13.25M
Enterprise Value
10.90M
1-Year Change
55.93%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since December 31, 2012, Can-Fite BioPharma's market cap has decreased from $37.20M to $13.25M, a decrease of -64.37%. That is a compound annual growth rate of -8.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 2, 2024 | 10.90M | 21.11% |
Dec 29, 2023 | 9.00M | -46.11% |
Dec 30, 2022 | 16.70M | -35.52% |
Dec 31, 2021 | 25.90M | -5.47% |
Dec 31, 2020 | 27.40M | 522.73% |
Dec 31, 2019 | 4.40M | -79.05% |
Dec 31, 2018 | 21.00M | 2.44% |
Dec 29, 2017 | 20.50M | -37.69% |
Dec 30, 2016 | 32.90M | 5.79% |
Dec 31, 2015 | 31.10M | 13.09% |
Dec 31, 2014 | 27.50M | -41.74% |
Dec 31, 2013 | 47.20M | 26.88% |
Dec 31, 2012 | 37.20M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
QT Imaging Holdings | 15.85M |
Alterity Therapeutics | 15.82M |
Talis Biomedical | 15.78M |
TRxADE HEALTH | 15.71M |
Sensei Biotherapeutics | 15.55M |
Talphera | 15.12M |
Evaxion Biotech | 15.12M |
Kintara Therapeutics | 14.94M |